EcoDrugPlus

Glucagon Like Peptide 1 Receptor

Ensembl ID : ENSG00000112164
Gene: GLP1R
Gene Synonyms: GLP-1R
13 APIs:
11 Enzyme and pathways 7 Cross references
133 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glucagon Like Peptide 2 Receptor

Ensembl ID : ENSG00000065325
Gene: GLP2R
Gene Synonyms:
3 APIs:
7 Enzyme and pathways 7 Cross references
205 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glucagon Receptor

Ensembl ID : ENSG00000215644
Gene: GCGR
Gene Synonyms: GGR
13 APIs:
11 Enzyme and pathways 8 Cross references
184 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glucokinase

Ensembl ID : ENSG00000106633
Gene: GCK
Gene Synonyms: HK4,MODY2
5 APIs:
18 Enzyme and pathways 9 Cross references
216 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glucosylceramidase Beta 1

Ensembl ID : ENSG00000177628
Gene: GBA1
Gene Synonyms: GBA,GLUC
1 APIs:
8 Enzyme and pathways 8 Cross references
245 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Ampa Type Subunit 1

Ensembl ID : ENSG00000155511
Gene: GRIA1
Gene Synonyms: GLUA1,GLUR1,GLURA
14 APIs:
22 Enzyme and pathways 8 Cross references
325 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Ampa Type Subunit 2

Ensembl ID : ENSG00000120251
Gene: GRIA2
Gene Synonyms: GLUA2,GLUR2,GLURB
14 APIs:
16 Enzyme and pathways 8 Cross references
322 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Ampa Type Subunit 3

Ensembl ID : ENSG00000125675
Gene: GRIA3
Gene Synonyms: GLUA3,GLUR3,GLURC,MRX94
13 APIs:
11 Enzyme and pathways 8 Cross references
249 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Ampa Type Subunit 4

Ensembl ID : ENSG00000152578
Gene: GRIA4
Gene Synonyms: GLUA4,GLUR4,GLURD
13 APIs:
11 Enzyme and pathways 8 Cross references
254 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Nmda Type Subunit 1

Ensembl ID : ENSG00000176884
Gene: GRIN1
Gene Synonyms: GLUN1,NMDAR1
24 APIs:
23 Enzyme and pathways 8 Cross references
276 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Nmda Type Subunit 2a

Ensembl ID : ENSG00000183454
Gene: GRIN2A
Gene Synonyms: GLUN2A,NMDAR2A
20 APIs:
17 Enzyme and pathways 8 Cross references
295 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Nmda Type Subunit 2b

Ensembl ID : ENSG00000273079
Gene: GRIN2B
Gene Synonyms: GLUN2B,NMDAR2B
24 APIs:
32 Enzyme and pathways 8 Cross references
335 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).